FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3010962502> ?p ?o ?g. }

• W3010962502 endingPage "398" @default.
• W3010962502 startingPage "389" @default.
• W3010962502 abstract "B-cell depletion is a common treatment of antibody-mediated rejection (ABMR). We sought to determine the specific immunopathologic effects of this therapeutic approach in kidney transplantation.This was a prospective observational study of kidney transplant recipients diagnosed with late ABMR (>3 months after transplant). Patients received treatment with pulse steroids, IVIG, and rituximab. Donor specific HLA antibodies (DSA), kidney allograft pathology, renal function, immune cell phenotypes, and 47 circulating cytokines were assessed at baseline and at three months.We enrolled 23 patients in this study between April 2015 and March 2019. The majority of patients were male (74%) and Caucasian (78%) with an average age of 45.6±13.8 years. ABMR was diagnosed at 6.8±5.9 years (4 months-25 years) post-transplant. Treatment was associated with a significant decline in circulating HLA class I DSA (P=0.003) and class II DSA (P=0.002) and peritubular capillaritis (ptc, P=0.04) compared to baseline. Serum creatinine, BUN, eGFR, and proteinuria (UPC) remained stable. Circulating B-cells were depleted to barely detectable levels (P≤0.001), whereas BAFF (P=0.001), APRIL (P<0.001), and IL-10 (P=0.02), levels increased significantly post-treatment. Notably, there was a significant rise in circulating CD4+ (P=0.02) and CD8+ T-cells (P=0.003). We also noted a significant correlation between circulating cytotoxic CD8+ T-cells and BAFF (P=0.05), regulatory T-cells and IL10 (P=0.002), and HLA class I DSA (P=0.005).Short-term pulse steroids/IVIG/rituximab therapy was associated with inhibition of ABMR (DSA and ptc), stabilization of kidney function, and increased regulatory B-cell and T-cell survival cytokines. Additional studies are needed to understand the implications of B cell-depletion on the crosstalk between T-cells, B-cells, and humoral components that regulate ABMR." @default.
• W3010962502 created "2020-03-23" @default.
• W3010962502 creator A5018901490 @default.
• W3010962502 creator A5025694734 @default.
• W3010962502 creator A5030789303 @default.
• W3010962502 creator A5035121982 @default.
• W3010962502 creator A5043981532 @default.
• W3010962502 creator A5048289307 @default.
• W3010962502 creator A5063450441 @default.
• W3010962502 creator A5064893146 @default.
• W3010962502 creator A5068836963 @default.
• W3010962502 creator A5072339369 @default.
• W3010962502 creator A5078233658 @default.
• W3010962502 creator A5080473599 @default.
• W3010962502 creator A5089415627 @default.
• W3010962502 creator A5090998388 @default.
• W3010962502 date "2020-05-01" @default.
• W3010962502 modified "2023-09-26" @default.
• W3010962502 title "Short-Term Immunopathological Changes Associated with Pulse Steroids/IVIG/Rituximab Therapy in Late Kidney Allograft Antibody Mediated Rejection" @default.
• W3010962502 cites W1576993812 @default.
• W3010962502 cites W1579460874 @default.
• W3010962502 cites W1618337835 @default.
• W3010962502 cites W1642153751 @default.
• W3010962502 cites W1758242630 @default.
• W3010962502 cites W1759641455 @default.
• W3010962502 cites W1935116877 @default.
• W3010962502 cites W1937775723 @default.
• W3010962502 cites W1938487222 @default.
• W3010962502 cites W1967797967 @default.
• W3010962502 cites W1976333624 @default.
• W3010962502 cites W1996725867 @default.
• W3010962502 cites W1998387067 @default.
• W3010962502 cites W2009501393 @default.
• W3010962502 cites W2009912209 @default.
• W3010962502 cites W2012751406 @default.
• W3010962502 cites W2019177796 @default.
• W3010962502 cites W2032253670 @default.
• W3010962502 cites W2039502927 @default.
• W3010962502 cites W2043152356 @default.
• W3010962502 cites W2051022408 @default.
• W3010962502 cites W2058664193 @default.
• W3010962502 cites W2059769534 @default.
• W3010962502 cites W2061888899 @default.
• W3010962502 cites W2074006404 @default.
• W3010962502 cites W2081695157 @default.
• W3010962502 cites W2102572875 @default.
• W3010962502 cites W2127001878 @default.
• W3010962502 cites W2127533496 @default.
• W3010962502 cites W2129422323 @default.
• W3010962502 cites W2137799668 @default.
• W3010962502 cites W2143041251 @default.
• W3010962502 cites W2148022022 @default.
• W3010962502 cites W2153516430 @default.
• W3010962502 cites W2160466593 @default.
• W3010962502 cites W2272827238 @default.
• W3010962502 cites W2288194547 @default.
• W3010962502 cites W2541158052 @default.
• W3010962502 cites W2588200867 @default.
• W3010962502 cites W2600340746 @default.
• W3010962502 cites W2749274444 @default.
• W3010962502 cites W2757341623 @default.
• W3010962502 cites W2765801442 @default.
• W3010962502 cites W2773812249 @default.
• W3010962502 cites W2774126255 @default.
• W3010962502 cites W2791209465 @default.
• W3010962502 cites W2793135200 @default.
• W3010962502 cites W2794125535 @default.
• W3010962502 cites W2809240358 @default.
• W3010962502 cites W2875249906 @default.
• W3010962502 cites W2900547575 @default.
• W3010962502 cites W2903245383 @default.
• W3010962502 cites W2912253072 @default.
• W3010962502 cites W2934791160 @default.
• W3010962502 cites W2938190699 @default.
• W3010962502 cites W2944474952 @default.
• W3010962502 cites W4250393576 @default.
• W3010962502 doi "https://doi.org/10.34067/kid.0001082019" @default.
• W3010962502 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8409258" @default.
• W3010962502 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34476406" @default.
• W3010962502 hasPublicationYear "2020" @default.
• W3010962502 type Work @default.
• W3010962502 sameAs 3010962502 @default.
• W3010962502 citedByCount "4" @default.
• W3010962502 countsByYear W30109625022020 @default.
• W3010962502 countsByYear W30109625022021 @default.
• W3010962502 countsByYear W30109625022023 @default.
• W3010962502 crossrefType "journal-article" @default.
• W3010962502 hasAuthorship W3010962502A5018901490 @default.
• W3010962502 hasAuthorship W3010962502A5025694734 @default.
• W3010962502 hasAuthorship W3010962502A5030789303 @default.
• W3010962502 hasAuthorship W3010962502A5035121982 @default.
• W3010962502 hasAuthorship W3010962502A5043981532 @default.
• W3010962502 hasAuthorship W3010962502A5048289307 @default.
• W3010962502 hasAuthorship W3010962502A5063450441 @default.
• W3010962502 hasAuthorship W3010962502A5064893146 @default.
• W3010962502 hasAuthorship W3010962502A5068836963 @default.
• W3010962502 hasAuthorship W3010962502A5072339369 @default.
• W3010962502 hasAuthorship W3010962502A5078233658 @default.

• next